コンテンツへスキップ
Merck

HIFN-130K

MILLIPLEX® Human Interferon Panel

Configurable Human Interferon 9-Plex Panel

ログインで組織・契約価格をご覧ください。

この商品について

NACRES:
NA.77
UNSPSC Code:
12161503


製品名

MILLIPLEX® Human Interferon Panel,

Quality Level

description

Configurable Human Interferon 9-Plex Panel

usage

 kit sufficient for 96 wells

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

parameter

25 μL sample volume (per well)

technique(s)

multiplexing: suitable

input

serum
plasma
cell culture supernatant(s)

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Interferons (IFNs) are widely expressed cytokines that have potent antiviral and antiproliferative effects. These cytokines are the first line of defense against viral infections and have important roles in immunosurveillance for malignant cells. IFNs are classified as type I, II and III IFNs, based upon the target receptors to which they bind. In humans, type I IFNs belong to a multigene family consisting of multiple IFNα subtypes but only one IFNβ, IFNε, IFNκ, and IFNψ. There is only one type II IFN: IFNγ. The type III IFNs include IFNλ1, λ2 and λ3, which are also known as interleukin-29 (IL-29), IL 28A and IL-28B, respectively. Functionally, the type I and type III IFNs are induced during a viral infection and involved in host defense against viruses. IFNγ (type II) is primarily involved in the allergic response, in host defense against intracellular pathogens, and in control of tumor growth. Studies of IFNs have broadened the mechanistic understanding of cell signaling, gene transcription, and innate and acquired immunity.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 9 analytes in human serum or plasma samples and tissue/cell lysate and culture supernatants.

Analytes included: IFNα-2, IFNβ, IFNε, IFNɣ, IFNɣ Receptor 1, IFNλ1, IFNλ2, IFNλ3, IFNΩ

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

  • Comprehensive Interferon Coverage: Simultaneously quantify all three interferon types (Type I, II, and III) including IFNα-2, IFNβ, IFNε, IFNγ, IFNγ Receptor 1, IFNλ1, IFNλ2, IFNλ3, and IFNψ in a single assay for complete interferon profile analysis.
  • Cost-Effective Sample Utilization: Maximize research efficiency by analyzing multiple interferon biomarkers from minimal sample volumes, reducing sample requirements for serum, plasma, tissue/cell lysate, and culture supernatant studies.
  • Verified Cross-Reactivity Performance: Achieve reliable results with negligible cross-reactivity between antibodies, ensuring accurate quantification of individual interferon analytes for precise inflammation and immunology research.
  • Viral Infection Research: Investigate the first line of defense against viral infections by simultaneously measuring type I and III interferons (IFNα-2, IFNβ, IFNε, IFNλ1, IFNλ2, IFNλ3, IFNψ) involved in antiviral host defense mechanisms.
  • Cancer Immunosurveillance Studies: Analyze interferon-mediated tumor control mechanisms by quantifying IFNγ and interferon receptor expression, supporting malignant cell immunosurveillance research and cancer immunotherapy development.

Legal Information

Luminex is a registered trademark of Luminex Corporation
xMAP is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


Still not finding the right product?

Explore all of our products under


signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

保管分類

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Please refer to KIT Component information

pdsc

Please refer to KIT Component information

prtr

Please refer to KIT Component information

fsl

Please refer to KIT Component information

ishl_indicated

Please refer to KIT Component information

ishl_notified

Please refer to KIT Component information

cart

キットコンポーネントの情報を参照してください

jan



試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする


関連コンテンツ

Explore how to select the best immunoassay platform for your research by choosing between multiplex and singleplex biomarker detection assays, immunoassay instrument platforms, immunoassay software, and services.

Immunology multiplex assays, like MILLIPLEX® assays, allow researchers to investigate more immune biomarkers simultaneously, saving time and resources.

Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.

すべての関連コンテンツを見る